These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

938 related items for PubMed ID: 19808968

  • 1. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
    Waltering KK, Helenius MA, Sahu B, Manni V, Linja MJ, Jänne OA, Visakorpi T.
    Cancer Res; 2009 Oct 15; 69(20):8141-9. PubMed ID: 19808968
    [Abstract] [Full Text] [Related]

  • 2. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S, Nayak S, Fernandes G, Barai RS, Menon S, Chaudhari UK, Kholkute SD, Sachdeva G.
    Endocr Relat Cancer; 2014 Jun 15; 21(3):473-86. PubMed ID: 24812058
    [Abstract] [Full Text] [Related]

  • 3. Changes of androgen receptor and insulin-like growth factor-1 in LNCaP prostate cancer cells treated with sex hormones and flutamide.
    Tong da Y, Wen XQ, Jin Y, Liu ZW, Sun HY, Zhou FJ, Wu XY.
    Asian Pac J Cancer Prev; 2010 Jun 15; 11(6):1805-9. PubMed ID: 21338237
    [Abstract] [Full Text] [Related]

  • 4. Identification of novel androgen receptor target genes in prostate cancer.
    Jariwala U, Prescott J, Jia L, Barski A, Pregizer S, Cogan JP, Arasheben A, Tilley WD, Scher HI, Gerald WL, Buchanan G, Coetzee GA, Frenkel B.
    Mol Cancer; 2007 Jun 06; 6():39. PubMed ID: 17553165
    [Abstract] [Full Text] [Related]

  • 5. Androgen receptor overexpression alters binding dynamics of the receptor to chromatin and chromatin structure.
    Urbanucci A, Marttila S, Jänne OA, Visakorpi T.
    Prostate; 2012 Aug 01; 72(11):1223-32. PubMed ID: 22212979
    [Abstract] [Full Text] [Related]

  • 6. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer.
    Urbanucci A, Sahu B, Seppälä J, Larjo A, Latonen LM, Waltering KK, Tammela TL, Vessella RL, Lähdesmäki H, Jänne OA, Visakorpi T.
    Oncogene; 2012 Apr 26; 31(17):2153-63. PubMed ID: 21909140
    [Abstract] [Full Text] [Related]

  • 8. Androgen-dependent regulation of Her-2/neu in prostate cancer cells.
    Berger R, Lin DI, Nieto M, Sicinska E, Garraway LA, Adams H, Signoretti S, Hahn WC, Loda M.
    Cancer Res; 2006 Jun 01; 66(11):5723-8. PubMed ID: 16740710
    [Abstract] [Full Text] [Related]

  • 9. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
    Fujimoto N, Miyamoto H, Mizokami A, Harada S, Nomura M, Ueta Y, Sasaguri T, Matsumoto T.
    Cancer Invest; 2007 Feb 01; 25(1):32-7. PubMed ID: 17364555
    [Abstract] [Full Text] [Related]

  • 10. Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription.
    Bebermeier JH, Brooks JD, DePrimo SE, Werner R, Deppe U, Demeter J, Hiort O, Holterhus PM.
    J Mol Med (Berl); 2006 Nov 01; 84(11):919-31. PubMed ID: 16932916
    [Abstract] [Full Text] [Related]

  • 11. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE, Shin JS, Leem DG, Kim SD, Cho WJ, Lee KT.
    Chem Biol Interact; 2016 Dec 25; 260():196-207. PubMed ID: 27720946
    [Abstract] [Full Text] [Related]

  • 12. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
    Schmidt A, Meissner RS, Gentile MA, Chisamore MJ, Opas EE, Scafonas A, Cusick TE, Gambone C, Pennypacker B, Hodor P, Perkins JJ, Bai C, Ferraro D, Bettoun DJ, Wilkinson HA, Alves SE, Flores O, Ray WJ.
    J Steroid Biochem Mol Biol; 2014 Sep 25; 143():29-39. PubMed ID: 24565564
    [Abstract] [Full Text] [Related]

  • 13. Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays.
    Kim HJ, Park YI, Dong MS.
    Toxicol In Vitro; 2006 Oct 25; 20(7):1159-67. PubMed ID: 16621434
    [Abstract] [Full Text] [Related]

  • 14. Effects of treatment with androgen receptor ligands on microRNA expression of prostate cancer cells.
    Segal CV, Koufaris C, Powell C, Gooderham NJ.
    Toxicology; 2015 Jul 03; 333():45-52. PubMed ID: 25846647
    [Abstract] [Full Text] [Related]

  • 15. GREB1 is a novel androgen-regulated gene required for prostate cancer growth.
    Rae JM, Johnson MD, Cordero KE, Scheys JO, Larios JM, Gottardis MM, Pienta KJ, Lippman ME.
    Prostate; 2006 Jun 01; 66(8):886-94. PubMed ID: 16496412
    [Abstract] [Full Text] [Related]

  • 16. Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells.
    Margiotti K, Wafa LA, Cheng H, Novelli G, Nelson CC, Rennie PS.
    Mol Cancer; 2007 Jun 06; 6():38. PubMed ID: 17553164
    [Abstract] [Full Text] [Related]

  • 17. Androgen receptor amplification is reflected in the transcriptional responses of Vertebral-Cancer of the Prostate cells.
    Makkonen H, Kauhanen M, Jääskeläinen T, Palvimo JJ.
    Mol Cell Endocrinol; 2011 Jan 01; 331(1):57-65. PubMed ID: 20728506
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of DHEA and DHT on gene expression in human LNCaP prostate cancer cells.
    Steele VE, Arnold JT, Lei H, Izmirlian G, Blackman MR.
    Anticancer Res; 2006 Jan 01; 26(5A):3205-15. PubMed ID: 17094431
    [Abstract] [Full Text] [Related]

  • 19. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ, Grigoryev DN, Nnane IP, Liu Y, Ling YZ, Brodie AM.
    Cancer Res; 2000 Dec 01; 60(23):6630-40. PubMed ID: 11118046
    [Abstract] [Full Text] [Related]

  • 20. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
    Altuwaijri S, Lin HK, Chuang KH, Lin WJ, Yeh S, Hanchett LA, Rahman MM, Kang HY, Tsai MY, Zhang Y, Yang L, Chang C.
    Cancer Res; 2003 Nov 01; 63(21):7106-12. PubMed ID: 14612503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.